Articles of the Month
Videos
Articles
Citations: 3117
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Citations: 2226
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R. Allergy. 2004; 59: 469-478
Citations: 1258
A revised nomenclature for allergy - An EAACI position statement from the EAACI nomenclature task force
Johansson, S.G.O., Hourihane, J., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T. et al. Allergy. 2001; 56: 813-824
Citations: 868
Position Paper - Allergen Standardization and Skin-Tests
Dreborg, S. and Frew, A. Allergy. 1993; 48: 49-54
Citations: 724
Allergenic pollen and pollen allergy in Europe
D’Amato, G., Cecchi, L., Bonini, S., Nunes, C., Annesi-Maesano, I., Behrendt, H. et al. Allergy. 2007; 62: 976-990
Citations: 723
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J. et al. Allergy. 2005; 60: 309-316
Citations: 709
The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
Zuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G., W., et al. Allergy. 2014; 69: 868– 887
Citations: 634
Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study
Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H.A., Halken, .S., Høst, A. et al. Allergy. 2007; 62: 943-948
Citations: 540
Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis
Wilson, D., R., Torres Lima, M. and Durham, S. R. Allergy. 2005; 60: 4-12
Citations: 1003
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 138
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Citations: 124
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Citations: 91
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Citations: 69
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Citations: 61
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Citations: 41
Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827
Citations: 40
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
Citations: 38
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444
Citations: 21
The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma
Eguiluz-Gracia, I., Mathioudakis, A.,G., Bartel, S., Vijverbeg, S., J., H., Fuertes, E. et al. Allergy. 2020; 75: 2170– 2184
The Maternal Diet Index in Pregnancy is associated with offspring allergic diseases: The Healthy Start Study
Venter, C., Palumbo, M.P., Glueck, D.H., Sauder, K.A., O’Mahony, L., Fleischer, D.M. et al. Allergy. 2021; first published: 21 May 2021
Invited review: The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji, M.H., Valenta, R., Jardetzky, T., Verhasselt, V., Durham, S.R., Wurtzen, P.A. and van Neerven, R.J. Allergy. 2021; first published: 17 May 2021
Eosinophils and activation markers after allergen challenge - a pilot study for three dimensional analysis in the bronchial mucosa
Prenzler, F., Tschernig, T., Sewald, K., Veres, T.Z., Rittinghausen, S., Krug, N., Hohlfeld, J.M. and Braun, A. Allergy. 2021; first published: 17 May 2021
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status
Fujieda, S., Matsune, S., Takeno, S., Ohta, N., Asako, M., Bachert, C., et al. Allergy. 2021; first published: 16 May 2021
Accurate and Reproducible Diagnosis of Peanut Allergy Using Epitope Mapping
Suárez-Fariñas, M., Suprun, M., Kearney, P., Getts, R., Grishina, G., Hayward, C., et al. Allergy. 2021; first published: 15 May 2021
Reply to “Acute scrotum in a 8-year-old Italian child caused by extraintestinal anisakiasis in a seaside area”
Morishima, R. Allergy. 2021; 76: 1603-1603
Acute scrotum in a 8-year-old Italian child caused by extraintestinal anisakiasis in a seaside area
Centonze, A., Capillo, S., Mazzei, A., Salerno, D., Sinopoli, D., Prosperi Porta, I. and Baldassarre, E. Allergy. 2021; 76: 1601-1602
ACE2 downregulation in olfactory mucosa: eosinophilic rhinosinusitis as COVID-19 protective factor?
Marin, C., Tubita, V., Langdon, C., Fuentes, M., Rojas-Lechuga, M.J., Valero, A., et al. Allergy. 2021; first published: 13 May 2021
Epigenetic regulation of epithelial dectin-1 through an IL-33-STAT3 axis in allergic disease
Yong, H.M., Gour, N., Sharma, D., Khalil, S.M., Lane, A.P. and Lajoie, S. Allergy. 2021; first published: 13 May 2021
News & Views: Groundbreaking Discoveries in Immunology The Epithelial Barrier Hypothesis: a 20-year journey
Pat, Y. and Ogulur, I. Allergy.First published: 12 May 2021
An injectable excipient prevents anti-polyethylene glycol antibody mediated hypersensitivity
Liu, Y., Smith, C.A., Payton, M., Jenkins, D., Janke, L.J. and Relling, M.V. Allergy. 2021;
Benralizumab Improves Symptoms of Patients with Severe, Eosinophilic Asthma with a Diagnosis of Nasal Polyposis
Canonica, G.W. et al. Allergy. First published: 12 May 2021
Innovative robust basophil activation test using a novel gating strategy reliably diagnosing allergy with full automation
Behrends, J., Schwager, C., Hein, M., Scholzen, T., Kull, S. and Jappe, U. Allergy. First published: 11 May 2021
Prof. Mario Sánchez Borges: An enduring legacy and a life well-lived
Pawankar, R., Rosenwasser, L.J. and Canonica, G.W. Allergy. First published: 10 May 2021
Distinction between peanut allergy and tolerance by characterization of B-cell receptor repertoires
Ehlers, A.M., den Hartog Jager, C.F., Knulst, A.C. and Otten, H.G. Allergy. First published: 10 May 2021
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Unexplained recurrent fever: when is autoinflammation the explanation?
Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course
Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Johnston, S.,L. Allergy. 2020; 75: 1543-1545
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
May 2021 - Food allergy and anaphylaxis
Volume 76 | Issue 5
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Basophil activation test: A diagnostic, predictive and monitoring assay for allergen immunotherapy
Alpan, O., Layhadi, J.A., Ulrik Sønder, S., Li, H. and Shamji, M.H. Allergy. 2021; 76: 1321-1324
Anaphylaxis to drugs: Overcoming mast cell unresponsiveness by fake antigens
Pichler, W.,J. Allergy. 2021; 76: 1340– 1349
The axis of the receptor for advanced glycation endproducts in asthma and allergic airway disease
Perkins, T.,N, Donnell, M.,L, Oury, T.,D. Allergy. 2021; 76: 1350– 1366
The global burden of illness of peanut allergy: A comprehensive literature review
Lieberman, J.,A, Gupta, R., Knibb, R.,C., Haselkorn, T., Tilles, S., Mack, D., P. and Poussel, G. et al. Allergy. 2021; 76: 1367– 1384
Butyrate as a bioactive human milk protective component against food allergy
Paparo, L, Nocerino, R, Ciaglia, E, et al. Allergy. 2021; 76: 1398– 1415
Predicting food allergy: The value of patient history reinforced
Lyons, SA, Knulst, AC, Burney, PGJ, et al. Allergy. 2021; 76: 1454– 1462
Identification of Pru du 6 as a potential marker allergen for almond allergy
Kabasser, S, Hafner, C, Chinthrajah, S, et al. Allergy. 2021; 76: 1463– 1472
Peanut-induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry
Maris, I., Dölle-Bierke, S., Renaudin, J.-M., Lange, L., Koehli, A., Spindler, T. et al. Allergy. 2021; 76: 1517-1527
Pollen induces reactivation of latent herpesvirus and differentially affects infected and uninfected murine macrophages
Speidel, J.D., Gilles, S., Steer, B., Vafadari, B., Rauer, D., Traidl-Hoffmann, C. and Adler, H. Allergy. 2021; 76: 1539-1542
PIPE-cloned human IgE and IgG4 antibodies: New tools for investigating cow's milk allergy and tolerance
Pranger, C.L., Fazekas-Singer, J., Köhler, V.K., Pali-Schöll, I., Fiocchi, A., Karagiannis, S.N. et al. Allergy. 2021; 76: 1553-1556
Assessing the protective role of allergic disease in gastrointestinal tract cancers using Mendelian randomization analysis
Yuan, S., Vithayathil, M., Kar, S., Carter, P., Mason, A.M., Xie, S.-H., Burgess, S. and Larsson, S.C. Allergy. 2021; 76: 1559-1562
Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitis
Werner, P. et al.
Trained immunity and allergy: State of the art and future perspectives
Wang, H., Song, J., Pan, L., Deng, Y.-K., Yao, Y., Wang, Z.-C. et al. Allergy. 2021; 76: 1565-1568
Elucidating the α-Gal syndrome at the molecular allergen level
Kiewiet, M.B.G., Grundström, J., Apostolovic, D., Andersson, M., Borres, M.P., Hamsten, C. et al. Allergy. 2021; 76: 1576-1578
The roadmap for allergology in Europe: The European training requirements for the specialty of allergology
Gerth van Wijk, R., Mülleneisen, N., Demoly, P., Olaguibel, J.M., Popov, T.A., Schmid-Grendelmeier, P. and Tsilochristou, O. Allergy. 2021; 76: 1588-1591
Junior Members Corner
ALLERGY COLLEGE 2021 - a JMA initiative to approach allergy and immunology to undergraduate students.
The Allergy College is an important initiative for increasing the visibility of our specialty among the future generation of scientists and clinicians across Europe. This year, a renewed virtual edition will take place during the 2021 EAACI Annual Hybrid Congress. The Allergy College is an excellent opportunity for undergraduate science and medical students to learn the challenges and rewards of starting a professional career in the field of Allergy and Immunology.
To apply, please send your CV and a short motivation letter. The selected students will receive waived digital registration for the Hybrid EAACI 2021 Congress. In addition, they will be matched with a mentor to prepare an abstract regarding a clinical case, a proposal for a scientific review or a short research study for presentation at the virtual Allergy College session.
Deadlines:
May 10: application deadline
May 20: matching with mentor
June 20: abstract submission deadline (250 words)
June 25: acceptance notification
We encourage you to promote this initiative amongst your medical and basic science undergraduate students and professional/academic network. If you are interested in collaborating as a mentor, please contact us for further information at the email address juniormembers@eaaci.org.
EAACI JM board representatives met with allergy fellows training in Turkey
The EAACI JM board in collaboration with the Turkish National Society of Allergy and Clinical Immunology (TNSACI) held a virtual meeting on April 18, 2021 for the allergy fellows training in Turkey. The aim of the meeting was to share knowledge and experiences about the educational and scientific opportunities offered by EAACI.
The meeting was hosted by Dr. Aslı Gelincik (foreign relations chair of the TNSACI Executive Committee (ExCom) and an EAACI member-at-large in the ExCom), and Dr. Stefano del Giacco (EAACI Education & Specialty VP). The EAACI JM board was represented by the JM board chair, Dr. Carmen Riggioni, and the secretary, Dr. Pasquale Comberiati.
The meeting topics were chosen based on a 22-question survey prepared by Drs Aslı Gelincik and Özge Aktaş Öztürk (TNSACI- EAACI National Societies Committee (NAS) JM representative). The survey was completed by the fellows in training and evaluated knowledge and expectations about JM activities and educational programmes. In this regard, Dr. Stefano del Giacco explained the structuring of EAACI and the novel and comprehensive “EAACI e-learning platform” which provides user-friendly resources including courses, webcasts, podcasts, lectures, and more.
Dr. Carmen Riggioni described the EAACI activities targeted to JMs such as the clinical and research Fellowship Programs, the Mentorship Program, scholarships for the EAACI congresses and meetings, the JM e-bulletin, the JM corners at Allergy and PAI journals’ websites and, in particular, the new collaboration between JMs and the EAACI journals that attracted considerable attention by the audience.
The meeting was attended by more than 300 young allergists in Turkey and gave more visibility to EAACI educational and scientific activities. Attendees felt the spirit of being part of the EAACI family in a friendly atmosphere. The EAACI JM board aims to organize additional meetings with JMs throughout Europe to motivate young allergists to engage with EAACI, which will contribute to their academic and scientific development.
Looking forward to meeting you all at the 2021 EAACI Annual Hybrid Congress!
Best regards,
The JMA
